🔗 Share this article

Texas Attorney General Ken Paxton is suing the manufacturers of Tylenol, claiming the firms concealed alleged dangers that the medication created to pediatric cognitive development.

The court filing comes thirty days after Donald Trump promoted an unproven link between using acetaminophen - also known as acetaminophen - during pregnancy and autism spectrum disorder in children.

Paxton is taking legal action against Johnson & Johnson, which once produced the drug, the exclusive pain medication approved for expectant mothers, and the current manufacturer, which presently makes it.

In a statement, he claimed they "misled consumers by profiting off of discomfort and promoting medication regardless of the risks."

Kenvue says there is lacking scientific proof tying acetaminophen to autism spectrum disorder.

"These companies deceived for years, knowingly endangering countless individuals to increase profits," the attorney general, a Republican, said.

The company stated officially that it was "deeply concerned by the spread of false claims on the security of acetaminophen and the possible consequences that could have on the welfare of US mothers and children."

On its online platform, the company also said it had "consistently assessed the applicable studies and there is no credible data that demonstrates a established connection between taking paracetamol and autism."

Groups acting on behalf of physicians and health professionals share this view.

The leading OB-GYN organization has stated acetaminophen - the primary component in acetaminophen - is a restricted selection for women during pregnancy to address pain and elevated temperature, which can create serious health risks if not addressed.

"In multiple decades of studies on the utilization of acetaminophen in gestation, no reliable research has successfully concluded that the consumption of paracetamol in any trimester of gestation causes neurodevelopmental disorders in children," the association stated.

The court filing references latest statements from the Trump administration in claiming the drug is potentially dangerous.

In recent weeks, the former president raised alarms from medical authorities when he advised expectant mothers to "resist strongly" not to take acetaminophen when sick.

The FDA then issued a notice that physicians should think about restricting the use of acetaminophen, while also mentioning that "a causal relationship" between the medication and autism in minors has remains unverified.

The Health Department head Robert F Kennedy Jr, who manages the FDA, had pledged in spring to conduct "comprehensive study program" that would identify the cause of autism in a matter of months.

But authorities cautioned that finding a unique factor of autism - thought by researchers to be the result of a complicated interplay of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of permanent neurological difference and impairment that influences how individuals perceive and interact with the environment, and is identified using physician assessments.

In his lawsuit, Paxton - who supports Trump who is campaigning for the Senate - alleges the manufacturer and J&J "deliberately disregarded and tried to quiet the evidence" around paracetamol and autism spectrum disorder.

The case seeks to make the companies "destroy any marketing or advertising" that asserts Tylenol is reliable for expectant mothers.

The court case parallels the grievances of a assembly of parents of young ones with autism and ADHD who filed suit against the producers of acetaminophen in recently.

The court dismissed the lawsuit, declaring studies from the family's specialists was inconclusive.